Gary Bray

2.1k total citations
23 papers, 933 citations indexed

About

Gary Bray is a scholar working on Hepatology, Epidemiology and Pharmacology. According to data from OpenAlex, Gary Bray has authored 23 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 9 papers in Epidemiology and 8 papers in Pharmacology. Recurrent topics in Gary Bray's work include Liver Disease Diagnosis and Treatment (9 papers), Liver Diseases and Immunity (9 papers) and Liver Disease and Transplantation (8 papers). Gary Bray is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Liver Diseases and Immunity (9 papers) and Liver Disease and Transplantation (8 papers). Gary Bray collaborates with scholars based in United Kingdom, United States and South Africa. Gary Bray's co-authors include Robert J. Williams, Philip M. Harrison, Rick Keays, Graeme Alexander, Bernard Portmann, Roger Williams, J. Michael Tredger, M Tredger, Roger Williams and A. M. Brind and has published in prestigious journals such as The Lancet, Hepatology and Gut.

In The Last Decade

Gary Bray

23 papers receiving 884 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Bray United Kingdom 13 538 379 359 156 126 23 933
Peter Trewby United Kingdom 13 359 0.7× 214 0.6× 132 0.4× 43 0.3× 244 1.9× 38 755
William S. Rosenthal United States 16 149 0.3× 154 0.4× 35 0.1× 91 0.6× 189 1.5× 41 788
S. G. Elkington United States 12 155 0.3× 287 0.8× 53 0.1× 53 0.3× 123 1.0× 20 739
Robert E. Weesner United States 17 697 1.3× 1.1k 2.9× 79 0.2× 20 0.1× 151 1.2× 26 1.7k
Antonio Rimola Spain 11 660 1.2× 437 1.2× 86 0.2× 30 0.2× 416 3.3× 18 903
Adeyinka Adejumo United States 18 275 0.5× 529 1.4× 41 0.1× 32 0.2× 164 1.3× 51 1.1k
Csilla Putz‐Bankuti Austria 14 303 0.6× 349 0.9× 56 0.2× 11 0.1× 138 1.1× 24 783
Guido Stirnimann Switzerland 18 400 0.7× 385 1.0× 102 0.3× 18 0.1× 271 2.2× 56 843
Van Thiel Dh United States 13 196 0.4× 150 0.4× 49 0.1× 8 0.1× 129 1.0× 45 538
P Sharpstone United Kingdom 14 49 0.1× 88 0.2× 35 0.1× 52 0.3× 112 0.9× 38 721

Countries citing papers authored by Gary Bray

Since Specialization
Citations

This map shows the geographic impact of Gary Bray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Bray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Bray more than expected).

Fields of papers citing papers by Gary Bray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Bray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Bray. The network helps show where Gary Bray may publish in the future.

Co-authorship network of co-authors of Gary Bray

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Bray. A scholar is included among the top collaborators of Gary Bray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Bray. Gary Bray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klinge, J., et al.. (2001). The Recombinate PUP Study Group. Low factor VIII recovery in haemophilia A patients without inhibitor titre is not due to the presence of anti-factor VIII antibodies undetectable by the Bethesda assay.. Haemophilia. 7(1). 2 indexed citations
2.
Davidson, Michael, Philip D. Harvey, C. A. Gagiano, et al.. (2000). A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. International Journal of Geriatric Psychiatry. 15(6). 506–514. 79 indexed citations
3.
Pereira, Stephen P., et al.. (1999). Non-invasive assessment of bone density in primary biliary cirrhosis. European Journal of Gastroenterology & Hepatology. 11(3). 323–328. 30 indexed citations
4.
Teare, Julian, Caroline Daly, Simon Padley, et al.. (1997). Pancreatic abnormalities and AIDS related sclerosing cholangitis.. Sexually Transmitted Infections. 73(4). 271–273. 12 indexed citations
5.
Brind, A. M., Gary Bray, Bernard Portmann, & R. Williams. (1995). Prevalence and pattern of familial disease in primary biliary cirrhosis.. Gut. 36(4). 615–617. 73 indexed citations
6.
Hulbert, Diana, et al.. (1995). The management of paracetamol overdose by junior doctors.. Emergency Medicine Journal. 12(1). 66–67. 5 indexed citations
7.
Teare, Julian, Simon Greenfield, R. P. H. Thompson, et al.. (1993). Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis. The Lancet. 342(8876). 895–898. 87 indexed citations
8.
Bray, Gary, et al.. (1993). Pericoronitis and accidental paracetamol overdose: a cautionary tale. BDJ. 174(2). 69–71. 16 indexed citations
9.
Bray, Gary, J. Michael Tredger, & Roger Williams. (1993). Resolution of danazol-induced cholestasis with S-adenosylmethionine. Postgraduate Medical Journal. 69(809). 237–239. 10 indexed citations
10.
Ronayne, Christina, et al.. (1993). The use of aqueous cream to relieve pruritus in patients with liver disease. British Journal of Nursing. 2(10). 527–528. 4 indexed citations
11.
Bray, Gary, M Tredger, & Roger Williams. (1992). S -adenosylmethionine protects against acetaminophen hepatotoxicity in two mouse models. Hepatology. 15(2). 297–301. 71 indexed citations
12.
Underhill, James A., Peter T. Donaldson, Gary Bray, et al.. (1992). Susceptibility to Primary Biliary Cirrhosis Is Associated With the Hla–Dr8–Dqb1*0402 Haplotype. Hepatology. 16(6). 1404–1408. 101 indexed citations
13.
Bray, Gary, Philip M. Harrison, John G. O’Grady, J. Michael Tredger, & Roger J. Williams. (1992). Long-Term Anticonvulsant Therapy Worsens Outcome in Paracetamol-Induced Fulminant Hepatic Failure. Human & Experimental Toxicology. 11(4). 265–270. 74 indexed citations
14.
Bray, Gary & Roger Williams. (1992). Immunointervention in primary biliary cirrhosis: an overview. Journal of Autoimmunity. 5. 293–300. 5 indexed citations
15.
Cole, Andrew J., et al.. (1992). Case report: Efficacy of verapamil in an elderly patient with mania unresponsive to neuroleptics. International Journal of Geriatric Psychiatry. 7(12). 913–915. 3 indexed citations
16.
Almasio, Piero Luigi, Gary Bray, G Budillon, et al.. (1992). Multicentre Survey of the Prevalence of Intrahepatic Cholestasis in 2520 Consecutive Patients with Newly Diagnosed Chronic Liver Disease. Clinical Drug Investigation. 4(S4). 83–89. 7 indexed citations
17.
Bray, Gary, Philip M. Harrison, Julia Wendon, J. Michael Tredger, & Robert J. Williams. (1992). New Approaches to Paracetamol Hepatotoxicity. Clinical Drug Investigation. 4(S4). 14–21. 3 indexed citations
18.
Bray, Gary, Craig Mowat, Douglas Muir, J. Michael Tredger, & Roger Williams. (1991). The Effect of Chronic Alcohol Intake on Prognosis and Outcome in Paracetamol Overdose. Human & Experimental Toxicology. 10(6). 435–438. 55 indexed citations
19.
Derkay, Craig S., Gary Bray, Gregory Milmoe, & Kenneth M. Grundfast. (1991). Adenotonsillectomy in Children With Sickle Cell Disease. Southern Medical Journal. 84(2). 205–208. 15 indexed citations
20.
Harrison, Philip M., Rick Keays, Gary Bray, Graeme Alexander, & Robert J. Williams. (1990). Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. The Lancet. 335(8705). 1572–1573. 266 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Trewby Breakdown of academic impact, for papers by William S. Rosenthal Breakdown of academic impact, for papers by S. G. Elkington Breakdown of academic impact, for papers by Robert E. Weesner Breakdown of academic impact, for papers by Antonio Rimola Breakdown of academic impact, for papers by Adeyinka Adejumo Breakdown of academic impact, for papers by Csilla Putz‐Bankuti Breakdown of academic impact, for papers by Guido Stirnimann Breakdown of academic impact, for papers by Van Thiel Dh Breakdown of academic impact, for papers by P Sharpstone
Rankless by CCL
2026